Join the Johns Hopkins Center for Health Security for a webinar, Enabling Population-Scale Diagnostic Testing for COVID-19 and Future Infectious Disease Outbreaks, on Wednesday, March 30, at 11am (ET).
Reliable and affordable access to rapid at-home and laboratory-based diagnostic testing capacity across the U.S. is a key component of a sustainable COVID-19 recovery plan. Making diagnostic testing increasingly ubiquitous can empower people to make informed decisions to limit the spread of COVID-19.
Throughout the pandemic, public-private partnerships have led to the development and wide-scale production of new rapid at-home diagnostics and expanded laboratory PCR-based testing capacity. However, it is a challenge to ensure long-term public access to testing capacity even during times when demand wanes. Overcoming the challenges posed by market volatility and supply chain issues is necessary to ensure accessible and accurate diagnostic testing for COVID-19.
This session will explore how policy makers can work to sustain technological gains made in diagnostic testing during the response to the COVID-19 pandemic, and how they can expand applications of this technology to other health security threats.
Moderator:
- Anita Cicero, JD, Deputy Director, Johns Hopkins Center for Health Security
Opening Remarks:
- Representative Lori Trahan (D-MA)
Speakers:
- Dr. Tom Inglesby, Senior Policy Advisor for Testing, White House COVID-19 Response Team
- Dr. Gigi Gronvall, Senior Scholar, Johns Hopkins Center for Health Security; Lead, COVID-19 Testing Toolkit
- Ms. Susan Van Meter, Executive Director, AdvaMedDx
- Dr. Rick Bright, Senior Vice President of Pandemic Prevention and Response, The Rockefeller Foundation (Invited)
A Q&A session will follow the moderated panel.
Please share this invitation with others in your network.
Registration: https://jh.zoom.us/webinar/register/WN_H1WwNuiNSC-1dgkUDGgOFw
